OrbiMed Raises $551 Million for Third Asia Healthcare Fund

09:18 EDT 6 Sep 2017 | ChinaBio Today

OrbiMed, a global healthcare investor, closed its third Asia private equity fund with $551 million in capital commitments, about $100 million more than the target listed in its initial filing six months ago. OrbiMed Asia Partners III will consider investments in all parts of Asia healthcare, but it expects to focus on growth-stage product and service companies in China and India. The Fund plans to make 15-20 investments that range from $10 to $75 million each. OrbiMed's two previous Asia funds totaled slightly less than $500 million. More details....

Share this with colleagues:

Original Article: OrbiMed Raises $551 Million for Third Asia Healthcare Fund


More From BioPortfolio on "OrbiMed Raises $551 Million for Third Asia Healthcare Fund"

Quick Search


Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...